Successful Treatment with Olanzapine of Psychosis in Dentatorubral-pallidoluysian Atrophy: A Case Report.
10.9758/cpn.2018.16.2.221
- Author:
Zui NARITA
1
;
Tomiki SUMIYOSHI
Author Information
1. Department of Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan. zuinarita@ncnp.go.jp
- Publication Type:Case Report
- Keywords:
Progressive myoclonic epilepsies;
Spinocerebellar degenerations;
Psychosis;
Antipsychotics
- MeSH:
Adult;
Antipsychotic Agents;
Humans;
Myoclonic Epilepsies, Progressive*;
Psychotic Disorders*;
Spinocerebellar Degenerations
- From:Clinical Psychopharmacology and Neuroscience
2018;16(2):221-223
- CountryRepublic of Korea
- Language:English
-
Abstract:
Patients with dentatorubral-pallidoluysian atrophy occasionally elicit psychosis. So far, one study reported first generation antipsychotics drugs may provide an effective treatment; however, there is no literature on the benefits of second generation antipsychotics. We report on a 44-year-old man with dentatorubral-pallidoluysian atrophy whose psychotic symptoms were effectively treated with olanzapine. Our observation suggests some second generation antipsychotics provide a therapeutic option for ameliorating psychosis in dentatorubral-pallidoluysian atrophy.
